Methylphenidate Actively Induces Emergence from General Anesthesia

Background: Although accumulating evidence suggests that arousal pathways in the brain play important roles in emergence from general anesthesia, the roles of monoaminergic arousal circuits are unclear. In this study, the authors tested the hypothesis that methylphenidate (an inhibitor of dopamine and norepinephrine transporters) induces emergence from isoflurane general anesthesia. Methods: Using adult rats, the authors tested the effect of intravenous methylphenidate on time to emergence from isoflurane general anesthesia. They then performed experiments to test separately for methylphenidate-induced changes in arousal and changes in minute ventilation. A dose–response study was performed to test for methylphenidate-induced restoration of righting during continuous isoflurane general anesthesia. Surface electroencephalogram recordings were performed to observe neurophysiological changes. Plethysmography recordings and arterial blood gas analysis were performed to assess methylphenidate-induced changes in respiratory function. Intravenous droperidol was administered to test for inhibition of methylphenidate's actions. Results: Methylphenidate decreased median time to emergence from 280 to 91 s. The median difference in time to emergence without methylphenidate compared with administration of methylphenidate was 200 [155–331] s (median, [95% CI]). During continuous inhalation of isoflurane, methylphenidate induced return of righting in a dose-dependent manner, induced a shift in electroencephalogram power from delta (less than 4 Hz) to theta (4–8 Hz), and induced an increase in minute ventilation. Administration of intravenous droperidol (0.5 mg/kg) before intravenous methylphenidate (5 mg/kg) largely inhibited methylphenidate-induced emergence behavior, electroencephalogram changes, and changes in minute ventilation. Conclusions: Methylphenidate actively induces emergence from isoflurane general anesthesia by increasing arousal and respiratory drive, possibly through activation of dopaminergic and adrenergic arousal circuits. The authors' findings suggest that methylphenidate may be useful clinically as an agent to reverse general anesthetic-induced unconsciousness and respiratory depression at the end of surgery.

[1]  E. Brown,et al.  General anesthesia and altered states of arousal: a systems neuroscience analysis. , 2011, Annual review of neuroscience.

[2]  E. Brown,et al.  General anesthesia, sleep, and coma. , 2010, The New England journal of medicine.

[3]  Q. C. Meng,et al.  A Conserved Behavioral State Barrier Impedes Transitions between Anesthetic-Induced Unconsciousness and Wakefulness: Evidence for Neural Inertia , 2010, PloS one.

[4]  Bijan Pesaran,et al.  Chronux: a platform for analyzing neural signals , 2009, BMC Neuroscience.

[5]  S. Cheetham,et al.  The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety , 2009, Neuropharmacology.

[6]  Tao Luo,et al.  Basal Forebrain Histaminergic Transmission Modulates Electroencephalographic Activity and Emergence from Isoflurane Anesthesia , 2009, Anesthesiology.

[7]  E. Brown,et al.  Faculty Opinions recommendation of The involvement of hypothalamic sleep pathways in general anesthesia: testing the hypothesis using the GABAA receptor beta3N265M knock-in mouse. , 2009 .

[8]  Michael T Alkire,et al.  Thalamic Microinfusion of Antibody to a Voltage-gated Potassium Channel Restores Consciousness during Anesthesia , 2009, Anesthesiology.

[9]  M. Maze,et al.  The Involvement of Hypothalamic Sleep Pathways in General Anesthesia: Testing the Hypothesis Using the GABAA Receptor β3N265M Knock-In Mouse , 2009, The Journal of Neuroscience.

[10]  Ralph Lydic,et al.  Adenosine A1 and A2A Receptors in Mouse Prefrontal Cortex Modulate Acetylcholine Release and Behavioral Arousal , 2009, The Journal of Neuroscience.

[11]  P. Lalley.  Opioidergic and dopaminergic modulation of respiration , 2008, Respiratory Physiology & Neurobiology.

[12]  K. Hanaoka,et al.  [General anesthesia for two patients taking methylphenidate (Ritalin)]. , 2008, Masui. The Japanese journal of anesthesiology.

[13]  N. Franks.  General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal , 2008, Nature Reviews Neuroscience.

[14]  Masashi Yanagisawa,et al.  An essential role for orexins in emergence from general anesthesia , 2008, Proceedings of the National Academy of Sciences.

[15]  B. Kocsis,et al.  Modulation of Hippocampal Theta Oscillation by Histamine H3 Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.

[16]  Michael T Alkire,et al.  Thalamic Microinjection of Nicotine Reverses Sevoflurane-induced Loss of Righting Reflex in the Rat , 2007, Anesthesiology.

[17]  D. Monti,et al.  The involvement of dopamine in the modulation of sleep and waking. , 2007, Sleep medicine reviews.

[18]  Anne W. Schmidt,et al.  Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. , 2007, European journal of pharmacology.

[19]  M. Janeiro,et al.  [Narcolepsy and anesthesia]. , 2007, Revista espanola de anestesiologia y reanimacion.

[20]  E. Eger,et al.  Do Dopamine Receptors Mediate Part of MAC? , 2006, Anesthesia and analgesia.

[21]  T. Jhou,et al.  Identification of Wake-Active Dopaminergic Neurons in the Ventral Periaqueductal Gray Matter , 2006, The Journal of Neuroscience.

[22]  K. McKeage,et al.  Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting. , 2006, Drugs.

[23]  C. Saper,et al.  Hypothalamic regulation of sleep and circadian rhythms , 2005, Nature.

[24]  P. Lalley,et al.  D1-dopamine receptor agonists prevent and reverse opiate depression of breathing but not antinociception in the cat. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  P. Lalley,et al.  Dopamine1 receptor agonists reverse opioid respiratory network depression, increase CO2 reactivity , 2004, Respiratory Physiology & Neurobiology.

[26]  S. Ǧērmane.  Droperidol — A drug for neuroleptanalgesia and for arresting hypertonic crises , 1978, Pharmaceutical Chemistry Journal.

[27]  Anthony G Hudetz,et al.  Cholinergic Reversal of Isoflurane Anesthesia in Rats as Measured by Cross-approximate Entropy of the Electroencephalogram , 2003, Anesthesiology.

[28]  G. Plourde,et al.  Antagonism of sevoflurane anaesthesia by physostigmine: effects on the auditory steady-state response and bispectral index. , 2003, British journal of anaesthesia.

[29]  Jun Lu,et al.  The &agr;2-Adrenoceptor Agonist Dexmedetomidine Converges on an Endogenous Sleep-promoting Pathway to Exert Its Sedative Effects , 2003, Anesthesiology.

[30]  T. Guo,et al.  The sedative component of anesthesia is mediated by GABAA receptors in an endogenous sleep pathway , 2002, Nature Neuroscience.

[31]  Y. Pawitan.  In all likelihood : statistical modelling and inference using likelihood , 2002 .

[32]  Maliha S. Nash,et al.  Handbook of Parametric and Nonparametric Statistical Procedures , 2001, Technometrics.

[33]  P Fiset,et al.  Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. , 2000, Anesthesiology.

[34]  D. Sheskin.  Handbook of Parametric and Nonparametric Statistical Procedures: Third Edition , 2000 .

[35]  D. Sheskin.  Handbook of parametric and nonparametric statistical procedures, 2nd ed. , 2000 .

[36]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[37]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[38]  P C Vijn,et al.  I.v. anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions. , 1998, British journal of anaesthesia.

[39]  David J. Sheskin,et al.  Handbook of Parametric and Nonparametric Statistical Procedures , 1997 .

[40]  D. Ririe,et al.  Unexpected interaction of methylphenidate (Ritalin®) with anaesthetic agents , 1997, Paediatric anaesthesia.

[41]  M. Dodson,et al.  Postoperative effects of methylphenidate. , 1980, British journal of anaesthesia.

[42]  D. K. Rorie,et al.  Droperidol, a Selective Antagonist of Postsynaptic α-Adrenoceptors in the Canine Saphenous Vein , 1980 .

[43]  A. L. Garkavi,et al.  Method of cyclic descent in the problem of best approximation , 1980 .

[44]  D. K. Rorie,et al.  Droperidol, a selective antagonist of postsynaptic alpha-adrenoceptors in the canine saphenous vein. , 1980, Anesthesiology.

[45]  G. Hill,et al.  Physostigmine reversal of postoperative somnolence , 1977, Canadian Anaesthetists' Society journal.

[46]  M. Degroot,et al.  Probability and Statistics , 1977 .

[47]  E. Eger,et al.  Anesthetic uptake and action , 1974 .

[48]  P. Young,et al.  Time series analysis, forecasting and control , 1972, IEEE Transactions on Automatic Control.

[49]  Michael D. Geurts,et al.  Time Series Analysis: Forecasting and Control , 1977 .

[50]  J. Adriani,et al.  DRUG ANTAGONISTS: THEIR USE IN ANESTHESIOLOGY… , 1961, Anesthesia and analgesia.

[51]  H. Roberts.  Postoperative administration of methylphenidate , 1961, Canadian Anaesthetists' Society journal.

[52]  Sarwerfoner Gj,et al.  The use of intravenous methylphenidate (ritalin) in psychiatric interviewing. , 1959 .

[53]  E. Koranyi,et al.  The use of intravenous methylphenidate (ritalin) in psychiatric interviewing. , 1959, Canadian Medical Association journal.

[54]  A. S. Gale.  The effect of methylphenidate (ritalin) on thiopental recovery. , 1958, Anesthesiology.

[55]  J. Sheets,et al.  Methylphenidate (ritalin) hydrochloride parenteral solution; preliminary report. , 1956, Journal of the American Medical Association.

[56]  W. O. Fenn,et al.  A barometric method for measuring ventilation in newborn infants. , 1955, Pediatrics.